Recent Finacing
Recent Raise
Diurnal develops Chronocort, a modified‑release hydrocortisone that replicates circadian cortisol delivery for treating adrenal insufficiency and congenital adrenal hyperplasia, and advances the therapy through clinical trials with industry partners.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors